Thrilled to see Bio ReFine Ltd., our pioneering portfolio company in interventional cardiology, achieve this incredible breakthrough with a successful first-in-human use! The Coriofix system represents a leap forward for mitral valve repair, offering a unique implant-less annuloplasty solution. This innovative approach simplifies the procedure, enabling physicians to provide safer, fully endovascular treatments that improve patient outcomes in managing mitral regurgitation. If you’re attending #TCT2024, don’t miss the chance to connect and discover how BioRefine is reshaping the future of interventional structural cardiology. #InnovationInHealth #HeartValveRepair #MedTech
We are excited to share that we recently performed the first successful first in human case at Rabin Medical Center (Israel) using our Coriofix system for transcatheter annuloplasty repair of the Mitral Valve. This achievement is a major step forward in advancing safe and efficient heart valve repair. BioRefine, an Israeli medical device company pioneering in interventional structural cardiology, has developed groundbreaking technology that enables physicians to perform implant-less annuloplasty repair of heart valves. Our system offers a simple, safe, and fully endovascular approach to address mitral valve regurgitation. If you’re attending TCT, we’d love to connect and share more about how Coriofix is transforming interventional structural cardiology. #TCT2024 #StructuralCardiology #MitralValveRepair #InnovationInHealthcare Leor Perl Ran Kornowski Amos Levi Avi Avner Yael Fridman Boaz Shenhav Beilinson Innovation Peregrine Ventures
Congrats Dvir Keren, Boaz Shenhav and team!!
Engineering Manager at Cardiovalve
1moCongratulations! Good luck 🙏